Intrinsic Value of S&P & Nasdaq Contact Us

Anebulo Pharmaceuticals, Inc. ANEB OTC

Other OTC • Healthcare • Biotechnology • US • USD

SharesGrow Score
49/100
2/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$6.00
+1100%

Anebulo Pharmaceuticals, Inc. (ANEB) has 13 known insider and institutional holders on record. The largest holder is 22NW Fund, LP with 1,703,577 shares. Other notable holders include Schneeberger Daniel and Cunningham, Richard Anthony.

ANEB Insider Ownership

Top Holder
22NW Fund, LP
1,703,577 shares
Buys (12 mo)
0
$0.00 value
Sells (12 mo)
0
$0.00 value
Top Insider Holders
# Name Role Shares Owned Last Filed Relative Size
1 22nw Fund, Lp Director 1,703,577 2022-09-30
100%
2 Schneeberger Daniel Chief Executive Officer 982,500 2021-05-06
58%
3 Cunningham, Richard Anthony Chief Executive Officer 316,352 2025-04-07
19%
4 Cundy Kenneth C Chief Scientific Officer 115,037 2025-04-07
7%
5 Allen Simon Chief Executive Officer 70,246 2022-12-13
4%
6 Parschauer Karah Herdman Director 30,425 2022-10-03
2%
7 Lawler Joseph F. 10 Percent Owner 13,236 2025-04-07
1%
8 Shah Bimal R. Director 6,618 2025-04-07
0%
9 Lin Kenneth Director 4,964 2025-04-07
0%
10 Aryeh Jason Director 4,964 2025-04-07
0%
11 Calloway Nathaniel Director 3,309 2025-04-07
0%
12 English Aron R. 10 Percent Owner 2,647 2025-04-07
0%
13 Kupchyk Areta Director 2,647 2025-04-07
0%

No ownership data available for ANEB.

Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message